A novel oral COVID-19 vaccine will be developed by Jerusalem-based Oramed Pharmaceuticals through a new company, Oravax Medical, using Oramed’s proprietary oral delivery technology and India-based Premas Biotech’s novel vaccine technology. In a pilot study performed on pigs, the vaccine candidate promoted systemic immunity via Immunoglobulin G (IgG), the most common antibody in blood and bodily fluids that protects against […]
The post Oral COVID Vaccine Candidate Produces Antibodies In Pigs first appeared on The Florida Star | The Georgia Star.